We developed and characterized a mouse model of elevated intraocular pressure (IOP) to investigate the underlying cellular and genetic mechanisms of retinal ganglion cell (RGC) death. IOP was unilaterally increased in C57BL/6J mice by photocoagulation of the episcleral and limbal veins. IOP was measured using an indentation tonometer. RGC survival was measured by retrograde labeling using DiI applied to the superior colliculous. The mechanism of RGC death was investigated using TUNEL staining, immunostaining for cleaved caspase-3, and Western blot for Bcl-2 and Bax expression. RT-PCR was used to measure changes in Bcl-2, Bax, Bad, Bak, P53, ICE and Fas. Mean IOP was increased in the treated eyes from 13 ± 1.8 to 20.0 ± 2.8 mm Hg at four weeks and 17 ± 2.2 mm Hg at eight weeks. RGC loss was 15.6 ± 3.4% at two weeks and 27.3 ± 4.5% at four weeks after laser photocoagulation. TUNEL staining and caspase-3 positive cells were increased in the ganglion cell layer (GCL) in the treated eyes and seldom found in the control eyes. Bcl-2 expression in control group was higher than in the experimental group, while Bax expression in the control group was less than in experimental group. This mouse model resulted in a consistent, sustained increase in IOP with a reduction in the number of RGCs in the treated eye. The RGCs in eyes with elevated IOP were TUNEL-positive, with increased caspase-3 and decreased Bcl-2, consistent with apoptosis as the mechanism of neuronal cell death.
Introduction
Primary open angle glaucoma (POAG) is the most common form of glaucoma and the second leading cause of blindness. POAG is defined by characteristic anatomic damage of the optic nerve, including optic disc cupping, the loss of retinal ganglion cells (RGCs), and the resulting functional defects of the visual field. It is widely accepted that although the level of intraocular pressure (IOP) is not the only risk factor, its incidence, severity, and progression consistently correlate with the occurrence of human glaucoma and reducing IOP is the only currently available treatment for decreasing the risk of progressive glaucomatous optic nerve damage. Lowering IOP has been shown to be effective in preventing the occurrence of glaucoma in ocular hypertensives (Kass, Heuer, & Higginbotham, 2002) , and in glaucoma patients, effective lowering of IOP decreases the risk of progressive visual loss (AGIS, 2000) . q Supported by an unrestricted grant from Research to Prevent Blindness, Inc., New York, NY, National Institutes of Health Grants EY04446, NIH Vision Core EY02520, the Retina Research Foundation of Houston, and the Neva and Wesley West Foundation.
Animal models of glaucoma
For this reason, animal models, including the monkey, rat and rabbit, of elevated IOP have been developed to investigate the mechanisms of glaucomatous damage and strategies for therapeutic intervention. Gaasterland and Kupfer (1974) described experimental IOP elevation in monkeys using excessive direct application of argon laser to the trabecular meshwork. Although anatomically the closest model to human glaucoma, this model is limited by the expense involved and the high and variable pressures obtained. Later, models of increased IOP in rats were developed using various techniques to block aqueous egress from the eye. These included hyperosmotic saline microinjection into limbal veins, cauterization of the large veins draining the anterior segment, and ablation of the limbal vessels with a laser to decrease outflow (Mittag, Danias, & Pohorenec, 2000; Sawada & Neufeld, 1999; Shareef, Garcia-Valenzuela, & Salierno, 1995) . The mouse has been extensively studied in many experimental fields because of the feasibility of using transgenic or knockout technology, as well as the relative ease of handling and relatively low cost when compared with other mammals (John, Anderson, & Smith, 1999) . Although very useful in evaluating some effects of elevated IOP, concerns remain about mouse strains with elevated IOP associated with anterior segment abnormalities in that other effects of these developmental changes could impact ocular structures and processes (John, Smith, & Savinova, 1998) . Additionally, the elevated IOP occurs between 6 and 12 months of age, making it less desirable for use as a model of elevated IOP as timing issues must be considered (Danias, Lee, & Zamora, 2003a) . This study also showed that there appears to be RGC loss in C57/ BL6 non-glaucomatous mice, although it started between 12 and 15 months of age, making the RGC loss later and less severe than in DBA/2 mice with elevated IOP (Danias et al., 2003a) . This again demonstrates the need for an acquired mouse model where the IOP elevation will occur early and predictably. Currently, nothing is known concerning the manifestations of RGC death in the presence of elevated IOP in the mouse.
Measurement of IOP in mice
It is therefore highly desirable to develop a mouse model of elevated IOP in wild-type animals for glaucoma research. A major obstacle for developing an elevated IOP wild-type mouse model has been that the globe of the mouse is small. Standard techniques to non-invasively measure IOP using available tonometers are not possible, and thus previous efforts to raise IOP in mouse eyes could not easily be evaluated. Invasive tonometers were developed to measure the IOP in mice by micropipette (Avila, Carre, & Stone, 2001) , glass microneedle (John, Hagaman, MacTaggart, Peng, & Smithes, 1997) , or microneedle (Aihara, Lindsey, & Weinreb, 2003) . These techniques have the advantage of directly measuring IOP, but the impact of puncturing the globe on the disease process and the impact on repetitive measurements is not fully understood. Recently, non-invasive IOP measuring devices have been developed including a modified Goldmann applanation tonometer (Cohan & Bohr, 2001 ) and a plunger device (Danias, Kontiola, Filippopoulos, & Mittag, 2003b) . Moreover, our lab has developed an indentation-type tonometer that can reliably measure mouse IOP. With this IOP measuring device, it is now possible to develop and characterize a mouse model of elevated IOP for studying genetic factors that are related to the causation, prevention and treatment of human glaucoma. A recent report of an alternative method of elevating IOP in mice using laser to induce angle-closure also demonstrated elevated IOP with a reduction of optic nerve cross-sectional area, mean axon density, and total number of axons in the treated eyes at 12 weeks posttreatment. This technique requires perforation of the cornea to flatten the anterior chamber prior to laser application (Mabuchi, Aibara, & Mackey, 2003) . Another model involves the injection of indocyanine green in the anterior chamber in conjunction with diode laser application that found changes in the ERG in eyes with elevated IOP (Grozdanic, Betts, & Sakaguchi, 2003) . Both of these models require perforation of the cornea that could potentially lead to findings related to the technique rather than the elevated IOP and additionally could affect subsequent non-invasive IOP measurement.
In this study, we developed an elevated IOP mouse model by argon laser photocoagulation of the episcleral and limbal veins of one eye, and monitoring the IOP of both eyes with this indentation-type tonometer. In order to evaluate whether it may represent a viable mouse model for human glaucoma, we carried out a series of experiments to assess the pathological changes of the photocoagulated eyes and evaluate apoptosis as a possible mechanism of RGC death in this mouse model of elevated IOP.
Materials and methods
All experiments were conducted and all laboratory animals were treated in accordance with the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research and approved by the Baylor College of Medicine Animal and Use Committee. Animals were housed under a 12-h light-12-h dark cycle with standard chow and water.
Chronic experimental glaucoma model in mice
Experimental elevation of IOP was induced unilaterally in 12 C57BL/6J mice, age <5 weeks. Approximately 80% of the mice used were female. For all experiments, the untreated right eyes served as the controls for the treated left eyes. Animals were anesthetized with intraperitoneal injection of ketamine (50 mg/kg) and xylazine (5 mg/kg) and placed on warming pads throughout the procedure. One eye of each animal underwent argon laser photocoagulation of the episcleral and limbal veins. A spot size of 50 lm, duration of 0.1 s, and power of 80-110 mW were applied to the visible vasculature within 1 mm of the limbus over 290 degrees and 15-20 spots on each episcleral vein using green-only argon laser (Coherent, CA). The corneas were moistened with balanced salt solution as needed throughout the procedure.
IOP measurement in a chronic glaucoma model

Indentation tonometer
A modified Schiotz-like indentation tonometer was designed and manufactured using aluminum for the platform, stainless steel for the base, and Teflon-coated titanium for the plunger (Carbtex Corporation, Houston, TX). The plunger weighed 253.1 mg with tip diameter of 809 lm and contact area of 0.514 mm. The tonometer was mounted on a micro-manipulator to enable vertical and horizontal excursions (Fig. 1 ).
Pressure calibration
Adult C57BL/6J mice were killed by an overdose of anesthesia with intraperitoneal injection of ketamine and xylazine and the eyes were removed. Immediately, to minimize any changes in tissue integrity, the mounted globe was cannulated with a sterile, 28-gauge needle through the optic nerve to prevent distortion of the globe anteriorly and to prevent any leakage from around the needle. Resistance was excessive with smaller bore needles or micropipettes such that reliable transducer outputs could not be consistently obtained. The needle was connected to a pressure transducer with a signal amplifier (model 90602; SpaceLabs, Inc.; Redmond, WA) and balanced salt solution (BSS) hanging on an intravenous (IV) pole. Actual IOP was read from the digital readout of the pressure transducer. IOP was varied and maintained at a given pressure by altering the height of the IV pole. This closed system was filled with BSS and all air bubbles were removed before cannulation.
Tonometer calibration
A single drop of BSS, using the 28-gauge needle on a tuberculin syringe, was dropped onto the cornea prior to the measurement of IOP. After the IOP was set at a given level by altering the height of the BSS bottle on the IV pole, the tonometer was slowly lowered onto the mounted globe on the axis normal to the apex of the central cornea until the first contact with the corneal surface was made. The position of the tonometer at the first contact was noted using the micrometer scale on the micro-manipulator. The tonometer was then further lowered until the upward movement of the tonometer tip was first noted. The position of the tonometer at the first upward movement of the tonometer tip was noted using the micrometer scale on the micro-manipulator. By subtracting the two positions noted on the scale of the micro-manipulator, total excursion of the tonometer was calculated. The entire procedure was performed under direct visualization using a vertically mounted microscope. The average of two measurements was made at IOP each level.
Statistical analysis was performed on a computer (Excel; Microsoft Corp., Redmond, WA). Known IOP from the pressure transducer was plotted against the excursion of the tonometer. Best-fit logarithmic regression curve was derived to calculate correlation coefficients. Paired t-test was used to detect inter-animal differences.
Non-invasive IOP measurement in live mice
After the mice were anesthetized using intraperitoneal injection of ketamine (50 mg/kg) and xylazine (5 mg/kg), they were placed on a stainless steel platform and gently immobilized using head and tail holders. Body temperature was maintained using a gentle heating lamp. BSS was placed on the eye to prevent corneal dehydration and to facilitate visualization. The mouse was placed in a holding device that was rotated in all three axes to allow the apex of the cornea to be normal to the vertically mounted tonometer tip for each eye to be measured. The tonometer tip was lowered onto the cornea and the excursion of the tonometer was measured using the method described above. All the procedures were performed under visual control using vertically-mounted microscope. Under direct microscopic observation, no posterior movement of the globe, representing retropulsion of the globe into the orbit, could be detected until the end point of the measurement. This is likely a result of the very light-weight titanium plunger weighing only 253.1 mg. The mean of five consecutive measurements was used. IOPs were measured prior to laser treatment, and at least weekly thereafter.
Ganglion cell retrograde labeling and cell counting
Two days before the animals were sacrificed, the RGCs were retrogradely labeled by the fluorescent tracer 1,1 0 -dioctadecy1-3,3,3 0 3 0 -tetramethylindocarbocyanine perchlorate (DiI), (Molecular Probes, Eugene, OR) as a 10% solution in dimethylformamide, using previously described techniques that involve the application of the tracer to the superior colliculi (SC) (Simon, Roskies, & OÕLeary, 1994) . In brief, the mice were anesthetized, each midbrain was exposed, and after removing the pia overlying the SC, DiI was introduced by pressure injection with a Picospritzer II (General Valve, Fairfield, NJ) through a glass micropipette (tip internal diameter, $50 lm), which was inserted into the SC. Mice were sacrificed two and four weeks after laser photocoagulation. Whole mounted retinas were examined under a confocal microscope. Specimens 2 and 4 mm from the optic disc were photographed in the four retinal quadrants. The number of DiI-labeled cells was counted in the photographs and the density of labeled RGCs/mm 2 was calculated by averaging the eight counts in each retina.
TUNEL staining for retinal sections
Retinas prepared for TUNEL staining and analysis were divided into three groups: (1) non-laser-treated eyes served as control; (2 and 3) laser-treated animals sacrificed at two weeks and four weeks after laser. Both eyes of all animals were enucleated and retinas were dissected free and fixed in 4% paraformaldehyde for 1 h. Retinal sections were washed three times in PBS (pH = 7.4). Flat-mounted retinas were cut transversely along the superior-inferior axis of the globe to ensure comparability. The sections were permeabilized in 0.1% Triton X-100 and 0.1% sodium citrate solution for 5 min followed by blocking in 3% H 2 O 2 for 15 min. Sections were incubated in TUNEL reaction mixture solution (Enzyme solution and label solution, Roche, Germany) overnight at room temperature. Slides were rinsed three times in PBS for 5 min each. Sections were then evaluated under the confocal microscope.
Immunostaining for cleaved caspase-3
Paraffin retinal sections were divided into two groups: control eyes; and laser-treated with elevated IOP at two weeks. Retinal sections were washed in PBS (pH = 7.4), incubated in blocking buffer (2% normal Goat serum and 0.2% Triton X-100 in PBS) for 1 h, and incubated in Cleaved caspase-3 FITC conjugated antibody (1:100, Cell Signaling Technology, England) for 24 h at 4°C. The sections were washed three times in PBS. The sections were evaluated under confocal microscopy.
Western blot for Bcl-2 and Bax expression
In order to quantify the factors known to modulate apoptosis, after laser treatment western blots were used to analyze the protein expression in the retinas. Fresh retinal tissue from control and treated eyes were extracted and homogenized in Tris-HCl 25 mM buffer consisting of 0.32 M sucrose, 1 mM EDTA, protease and phosphatase inhibitor cocktails (Sigma, MO). Lysates were centrifuged and the resulting supernatants were collected and protein concentrations were determined by BCA assay. Samples were mixed with sample buffer, heated at 99°C for 5 min, and 100 lg of total protein was loaded onto 15% SDS-polyacrylamide gel for eletrophoresis and staining.
For immunoblotting analysis, proteins were transferred onto nitrocellulose membranes. A blocking buffer of Tris-base, 0.1% Tween 20 containing 5% non-fat powdered milk was used for all incubations. Blots were probed for 2 h at room temperature with primary antibody (1:100, Bcl-2; 1:500, Bax; 1:500, b-actin; 1:1000). Blots were rinsed three times for 10 min each in TBST, and were incubated for 1 h at room temperature with HRP-conjugated IgG (Goat anti-Rabbit for Bcl-2 and Bax, 1:2000, Cell Signaling Technology, England; Goat anti-mouse for b-actin, Sigma, America). Membranes were washed in TBST and immunoreactive proteins were detected using the enhanced chemiluminescence method (ECL, Amersham).
RNA isolation and semi-quantitative RT-PCR
Total RNA was isolated from retinas by acid guanidium thiocyanate-phenol-chloroform extraction using a previously described method (Li & Tseng, 1995) . The RNA was quantified by measuring the absorption at 260 nm, a fraction was electrophoresed through 1.2% agarose, 2.2 M formaldehyde gel to verified its integrity, and stored at À80°C before use.
With a housekeeping gene, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), as internal control, expression of Bcl-2, Bax and P53 genes was analyzed by semi-quantitative RT-PCR using a previously described method (Li & Tseng, 1995) . In brief, the firststrand cDNAs were synthesized from 1 lg of total RNA using 50 units of MuLV reverse transcriptase, 20 units of RNAse inhibitor and 50 pmol of oligo(dT)16 as a primer in a 20 ll reaction solution at 42°C for 30 min. PCR amplification of the first-strand cDNAs was performed by mixing 20 ll of the reverse transcription reaction with 80 ll of buffer containing 2.5 units of Taq DNA polymerase and 25 pmol of specific primer pairs for mice Bcl-2, Bax, P53 and GADPH, designed from published human gene sequences (Apte, Mattei, & Olson, 1995; Cascino & Ruberti, 1995; Harlow et al., 1985; Tso & Sun, 1985; Tsujimoto & Croce, 1986; Yang & Korsmeyer, 1995) . The PCR was performed in a Perkin-Elmer DNA Thermal Cycler 480 using the following reaction sequence: first denaturation for 2 min at 95°C followed by 20-40 cycles of denaturation for 1 min at 95°C, annealing for 1 min at 60°C and extension for 1 min at 72°C; last extension for 7 min at 72°C. Semi-quantitative RT-PCR was established by terminating reactions at intervals of 20, 24, 28, 32, 36 and 40 cycles for each primer pair to ensure that the PCR products formed were within the linear portion of the amplification curve. The RT-PCR products were visualized on 1.5% agarose gels electrophoresed in 1· TAE buffer containing 0.5 lg/ml ethidium bromide. The fidelity of the RT-PCR product was verified by comparing the size of the amplified products to the expected cDNA bands and by sequencing the PCR products.
Results
Tonometer calibration
Plotting the tonometer reading against the transducer (true) IOP in enucleated eyes (n = 18) produced a regression curve as shown in Fig. 2 , with a formula of y = À 13.908Ln(x) + 97.096 (R 2 = 0.8753).
IOP measurement in wild-type live mouse
Measured IOP using the indentation tonometer in conjunction with the derived regression curve in a strain of non-glaucomatous mice (C57BL/6J, n = 6) was 11.2 ± 0.67 mm Hg (mean ± SD). This IOP range is consistent with the reported norm for this particular mouse strain (Avila et al., 2001; Sarinova et al., 2001) , which further confirms the validity of our tonometer. IOP did not differ significantly among normal mice (p > 0.6) as would be expected within a single strain (Sarinova, Sugiyama, & Martin, 2001 ).
Elevated intraocular pressure
The mean IOP in animals under general anesthesia and before treatment was 13 ± 1.8 mm Hg. Approximately 90% of treated eyes in this study had elevated IOP. The mean IOP in the laser-treated eyes (n = 6) was 20 ± 2.8 mm Hg, significantly higher than that in the control eyes at each time point during the first four weeks following laser treatment (p < 0.01), but with time, the IOP decreased slightly through seven to eight weeks after laser photocoagulation, the duration of this study (Fig. 3) . At eight weeks (n = 5), the IOP was 17 ± 2.2 mm Hg. There was no need to repeat laser treatment after the first session since an adequate elevation of IOP was obtained and maintained over the study period.
Loss of retinal ganglion cells after laser photocoagulation
The retinal ganglion cells retrogradely labeled by DiI detected under confocal microscopy were quantified comparing the density of RGCs in experimental eyes with elevated IOP and control eyes. In the weeks following laser photocoagulation, the density of RGCs in control (n = 5), two-week glaucomatous group (n = 5) and four-week glaucomatous group (n = 5) is 77.2, 64.8 and 55.5 RGCs/lm 2 , respectively, and the percentage of RGCs lost in the treated eyes with elevated IOP compared to the untreated controls was 15.6 ± 3.4%. This was a statistically significant difference (p = 0.0345). At four weeks, the death rate of RGCs was 27.3 ± 4.5%, which was also a statistically significant difference between control (n = 5) and glaucomatous groups(n = 5) (p = 0.0072) (Figs. 4 and 5) .
TUNEL staining
Apoptosis is suggested to be the possible mode of RGC death in glaucoma. TUNEL-positive stained cells were observed only in the ganglion cell layer (GCL). Very few positive TUNEL cell staining was detected (3 ± 1) in each section from control retinas (n = 3). At two weeks post-laser (n = 3), the number of TUNELpositive cells in GCL in each section was increased significantly (25 ± 3, p < 0.01). Four weeks after laser (n = 3), the TUNEL-positive cells in GCL remained at increased levels compared to controls (18 ± 2, p < 0.01) (Fig. 6 ).
Immunostaining for cleaved caspase-3
Caspase-3 is one of the key executioners of apoptosis, being responsible either partially or totally for the proteolytic cleavage of many key proteins in the apoptotic process. Fig. 7 shows that caspase-3 positive cells were observed in the ganglion cell layer (GCL) and rarely in the inner nuclear layer (INL) in treated eyes with elevated IOP. Caspase-3 positive cells were seldom found in any retinal layer in the control eyes (n = 3) and more frequently in the experimental group (n = 3) 12 ± 3 vs. control group 2 ± 2 per section (Fig. 7) .
Western blotting for Bcl-2 and Bax
The Bcl-2 family of genes is an important modulator of apoptosis. Bcl-2 is a anti-apoptotic gene, whereas Bax is proapoptotic. Recently it has been reported that retinal ganglion cell survival and axon regeneration can be supported through a Bcl-2-dependent mechanism (Huang, Wu, & Chen, 2003) . In this study, Bcl-2 and Bax expression in the retina were used to assess the control of apoptosis in RGCs after laser treatment. The results showed that Bcl-2 expression in the control eyes (n = 3) was higher than that in the photocoagulated eyes (n = 3). On the contrary, Bax expression in control eyes was less than that in experimental eyes. The ratio of Bcl-2 to Bax showed that the net intensity in control group was significantly higher than that in experimental group (p < 0.05) (Fig. 8) . These results are consistent with the Bcl-2 family being involved in the upstream of the regulation of apoptosis of RGCs in this model resulting in RGC death.
RT-PCR
Representative semi-quantitive RT-PCR profiles of mRNA expression of Bcl-2, Bax, Bad, Bak, p53, Fas, ICE. Total RNA was extracted from control (n = 10) and mouse retinas with elevated IOP two weeks following laser photocoagulation (n = 10). RT-PCR was performed using an equal amount of total RNA and was analyzed at intervals of four cycles from 40 to 60 PCR cycles, and with GADPH as an internal control. 100-bp DNA ladder was run in parallel. The results showed that the expression of anti-apoptotic gene Bcl-2 and Bad, are higher in normal retinas compared with the glaucomatous retinas. On the contrary, apoptotic genes Bax, Bak, P53, Fas and ICE are higher in glaucomatous groups (see Fig. 9 ).
Discussion
The mouse model of elevated IOP is an advantageous animal model for human glaucoma.
In this study, we have developed an acquired mouse model of moderately elevated IOP in wild-type animals. There is loss of RGCs in the treated eyes with characteristics consistent with apoptosis as the mechanism of cell death. Therefore, it appears to have great potential as an animal model for glaucoma.
The mouse has been extensively studied in many experimental fields because of the feasibility of using transgenic or knockout technology, as well as the relative ease of handling and relatively low cost when compared with other mammals (John et al., 1999) . Moreover, the mouse eye has many structural similarities to the human eye including a well-defined trabecular meshwork, SchlemnÕs canal, ciliary body and vascularized retina (John et al., 1999) . However, due to the technical difficulty in non-invasively measuring IOP, an acquired, chronic model of elevated IOP to study glaucoma has not been established in mice. The development of non-invasive tonometry in mice has opened the possibility of developing and characterizing a mouse model of elevated IOP. The non-invasive tonometer we have developed and used for this study demonstrated an adequate level of accuracy for this purpose. It has been calibrated with enucleated eyes since the small size of the mouse globe places technical barriers that prevent placement of a large enough needle to allow calibration without distorting the anterior surface of the globe in vivo. Although currently IOP measurement requires general anesthesia, future developments may remove this step. Furthermore short periods of anesthesia have been shown to have no effect on IOP in mice (Sarinova et al., 2001 ). However, since each animal provides its own control, it is unlikely that general anesthesia diminishes the study findings appreciably and this also limits the possible impact of the loss of RGCs in aged nonglaucomatous eyes that has been shown (Danias et al., 2003a) .
A mouse strain with elevated IOP has been described, however in that model there are associated developmental anterior segment anatomic abnormalities potentially affecting the response to IOP elevation (John et al., 1998) . It is difficult to compare the loss of RGCs from this strain and from our model since that DBA/2 strain did not show RGC loss until approximately 12 months of age, with 64% of RGCs dying by the fifteenth month, even though IOP returned to lower, early (three months of age) levels from months 12-18 (Danias et al., 2003a) . Using the experience from the glaucoma model of elevated IOP in rats that have been successfully established and characterized, similar methods were used in this study in mice. In the rat model of elevated IOP induced by argon laser, it was shown that there was a twofold IOP increase over baseline resulting in a 27-30% loss of RGCs at two months (Mittag et al., 2000) . Laser photocoagulation was used to decrease aqueous outflow and increase the IOP. This approach in mice successfully produced elevated IOP in nearly 90% of treated eyes, with a mean pressure of 23 mm Hg. Two and four weeks after treatment, the number of RGCs had been reduced by 15.6% and 27.3%, respectively, compared to normal, untreated eyes. The ratio of DiI positive cells compared to the number of nuclear stained cells closely approximated the percentage of RGCs in the mouse ganglion cell layer reported by Jeon, Strettoi, and Masland (1998) . Direct retrograde labeling was used recognizing that this could be affected by changes in retrograde transport resulting from abnormal function in dying RGCs. The similarity of these models is that there is a modest elevation of IOP and chronic RGC death in experimental eyes. However, there is a slight difference in death rate and level of IOP between these two models. For this mouse model, the power, duration, and number of the laser applications are less than those in the rat because the smaller scale of the mouse globe. However, our data suggest that this mouse model represents a Fig. 8 . Western blot analysis for Bcl-2 and Bax. The control blots are on the left, the experimental on the right. The Bcl-2/Bax ratio (optical density) in control eyes was significantly higher than that in experimental group (p < 0.05). Fig. 9 . Representative semi-quantitive RT-PCR profiles of mRNA expression of Bcl-2, Bax, Bad, Bak, p53, Fas, ICE. Total RNA was extracted from control (C) and mouse retinas with elevated IOP for two weeks (G). RT-PCR was performed using an equal amount of total RNA and was analyzed at intervals of four cycles from 40 to 60 PCR cycles, and with GADPH as an internal control. 100-bp DNA ladder was run in parallel. valid model of elevated IOP with loss of RGCs. A recent report of an alternative method of elevating IOP in mice using laser to induce angle-closure also demonstrated elevated IOP with a reduction of optic nerve cross-sectional area, mean axon density, and total number of axons in the treated eyes at 12 weeks post-treatment (Mabuchi et al., 2003) . However, this technique requires perforation of the cornea to flatten the anterior chamber prior to laser application. This microneedle perforation could affect ocular structures resulting in changes not related to elevated IOP alone. Additionally, if this model is used with a non-invasive method of IOP measurement, the perforation could affect corneal structure and the IOP measurement.
The mouse has distinct advantages compared to all other models in that the mouse provides the potential for rapid, inexpensive direct genetic manipulation unavailable in other species and this model uses wild-type animals without other known ocular abnormalities. Compared to other species, the elevation of IOP is more modest in the mouse than in the rat or monkey, thus appears to more closely approximating the human glaucomatous condition. In addition, only a single laser treatment of lower energy is needed, unlike the other acquired animal models. There is no evidence that the laser application results in scarring of the limbal area that could potentially alter subsequent tonometry.
The mouse model of elevated IOP is consistent with the apoptotic RGC death hypothesis derived from human glaucoma studies.
Apoptosis is a genetically controlled form of cell death that neurons undergo normal development as well as disease (Nickells, 1999) . There is evidence to suggest that ganglion cells die in spontaneous or experimental glaucoma by apoptosis (Quigley, Nickells, & Kerrigan, 1995; Wax, Tezel, & Edwards, 1998) . Much of what we know at the basic science level has been from the study of experimental glaucoma in monkeys. In this primate model, early light and electron microscope observations of the RGCs indicated that dying cells exhibited many of the features now known to be consistent with apoptosis (Kerrigan, Zack, & Quigley, 1997) . Further evidence of apoptosis in experimental glaucoma has been obtained by assaying ganglion cells for DNA fragmentation. Monkeys exhibit at least 10 times more TUNEL-positive RGCs in eyes with experimental glaucoma than in control eyes (Kerrigan et al., 1997) . More recent studies on rats with elevated IOP have confirmed the TUNEL findings supporting apoptotic RGC death. Additionally, studies have extended and confirmed the TUNEL findings by demonstrating multiple markers of apoptotic degradation in RGC layer cells in human retina from patients with glaucoma (Kerrigan et al., 1997; Okisaka et al., 1997; Tatton et al., 2001; Wax et al., 1998) . The number of cells that are TUNEL-positive at any single time point exceed the number one would predict based upon the total number of RGCs lost during the course of this study. Although TUNEL staining alone may not be specific for detecting apoptosis, combined with our further investigations, it is consistent with apoptosis occurring. Our study showed that TUNEL positive cells were present in the ganglion cell layer in the experimental eyes and few positive cells were found in control eyes or elsewhere in the retina.
Caspase-3 plays a central role as an effector of DNA fragmentation (Nickells, 1999) . The increase in caspase-3 in the treated eyes is consistent with increased RGC death by apoptosis following IOP elevation. The Bcl-2 related group of proteins are critical modulators of apoptosis. Studies have shown that overexpression of Bcl-2 protects neurons against oxidative challenge (Lawrence, Ho, Sun, & Steinberg, 1996) . Bcl-2 can inhibit the formation of permeability transition pore, which controls cytochrome C release from mitochondria. However, Bax, induces the formation of new pores and results in the cell death. Moreover, Bcl-2 can block activation of caspases and participates upstream from the function of ICE/CED-3 protease and may inhibit apoptosis by preventing the post-translational activation of protease. Our findings of increased proapoptotic factors Bax in the eyes with elevated IOP again supports an increase in apoptosis compared to the control eyes. Conversely, the reduced expression of the anti-apoptotic factor Bcl-2 in the treated eyes is consistent with the previous findings. Our study suggests that apoptosis is responsible for RGC loss in this mouse model of elevated IOP by several different techniques that are consistent, thus supporting this model as a viable glaucoma since apoptosis is strongly implicated as a cause of RGC death in human glaucoma.
Limitations of the present model and conclusions
There are limitations to this study. Using a new tonometer introduces a source of error. However, the device was calibrated using a pressure transducer, and extreme accuracy, particularly given the recent controversy in human tonometry, is not mandatory. Given the correlation of normal mouse IOP with this tonometer and other existing devices and the marked differences between the treated and control eyes, even if a small amount of inaccuracy is introduced, it would not impact the results appreciably. Additionally, although this study presents multiple techniques consistent with RGC death by apoptosis, additional studies will be needed to determine if this is the only mechanism of cell death present. It appears that at least some RGCs are apoptotic in this model of elevated IOP based upon TU-NEL staining and the changes in known effectors of apoptosis. Finally, the question of how representative this model is compared to human glaucoma remains.
Although the preliminary results presented are quite encouraging, it remains for future investigations to confirm and define how closely the pathophysiology of this mouse model of elevated IOP resembles human glaucoma.
In conclusion, our study provides evidence for retinal ganglion cell death in mice with elevated intraocular pressure. Moreover, the loss of RGCs appears to be due to apoptosis and is associated with axonal degeneration. Given these findings, it makes this mouse model a viable tool in the investigations of glaucoma aimed at slowing the progression of the neurodegenerative process. Given the numerous candidate genes identified in human glaucoma, there is no doubt that genetic and molecular advances made possible by this model represent powerful techniques in the ongoing investigations as to the mechanisms of glaucoma and gene function in the future. The ultimate purpose of the development of a mouse model of elevated IOP is to use it to better understand and hopefully be more effective in treating and preventing human glaucoma.
